Haematological profile of HIV positive adults co-infected with pulmonary tuberculosis: a nested cross-sectional study in Uganda
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20261014Keywords:
Anemia, Hematological parameters, HIV, TB/HIV coinfection, TuberculosisAbstract
Background: Tuberculosis an endemic disease in Uganda contributes to over 30% of deaths among people living with HIV (PLHIV). Challenges in early diagnosis and monitoring common in limited resource settings underscore the need for more cost effective and reliable methods to improve patient outcomes. Hematological parameters have emerged as potential markers for predicting and monitoring TB disease. This study aimed to evaluate the hematological parameters among HIV/TB co-infected patients enrolled from both outpatient and inpatient health facility settings in Uganda.
Methods: A nested cross-sectional study involving 120 participants (active-TB-40; latent-TB-25; no-TB-55) was conducted from June 2024 to May 2025 at Kisenyi HCIV (outpatient) and Kiruddu Hospital (inpatient) in Uganda. Venous blood was collected in ethylene diamine tetra acetic (EDTA) tubes and analyzed using flow cytometry technique. C-reactive protein (CRP) was measured using the immunoturbidimetry and nephelometry method. Data obtained was analyzed using Stata version 23.
Results: The active-TB group showed lower red blood count, hemoglobin, hematocrit, mean cell hemoglobin and mean cell volume compared to the latent-TB and no-TB groups (p=0.001). CRP was significantly higher in the active TB group (p=0.001). The active-TB group had high total WBC count (p=0.02) with increased neutrophil count (p=0.003). No significant differences were observed in lymphocyte counts across the 3 patient groups (p=0.217).
Conclusions: Hematological parameters provide a reliable tool for risk profiling and monitoring among PLHIV coinfected with TB especially in resource limited settings. Therefore, integrating these parameters in routine care and management for TB/HIV patients may improve patient outcomes.
Metrics
References
World Health Organization. Global Tuberculosis Report 2020. World Health Organization. 2020. Available from: https://iris.who.int/server/api/core/ bitstreams/b1692b45-a92a-4871-8392-72080827ea6d/content. Accessed on 23 October 2025.
World Health Organization. Country Disease Outlook: Uganda.; 2023. Available from: https://www.afro.who.int/sites/default/files/2023-08/Uganda.pdf. Accessed on 23 October 2025.
Aturinde A, Farnaghi M, Pilesjö P, Mansourian A. Spatial analysis of HIV-TB co-clustering in Uganda. BMC Infect Dis. 2019;19(1):612. DOI: https://doi.org/10.1186/s12879-019-4246-2
Sankar P, Mishra BB. Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis. Front Immunol. 2023;14. DOI: https://doi.org/10.3389/fimmu.2023.1260859
Flynn JL, Chan J. Immune cell interactions in tuberculosis. Cell. 2022;185(25):4682-702. DOI: https://doi.org/10.1016/j.cell.2022.10.025
Jean K, Gabillard D, Moh R, Danel C, Fassassi R, Desgrées-du-Loû A, et al. Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Cote d'Ivoire. J Infect Dis. 2014;209(3):431-40. DOI: https://doi.org/10.1093/infdis/jit470
Kanabalan RD, Lee LJ, Lee TY, Chong PP, Hassan L, Ismail R, et al. Human tuberculosis and Mycobacterium tuberculosis complex: A review on genetic diversity, pathogenesis and omics approaches in host biomarkers discovery. Microbiol Res. 2021;246:126674. DOI: https://doi.org/10.1016/j.micres.2020.126674
Ongwae JM, Musyoki SK, Mongare S. Profile of haematological indices among pulmonary tuberculosis patients attending Kisii teaching and referral hospital, Kenya. Int J Community Med Public Health. 2023;10(8):2669-75. DOI: https://doi.org/10.18203/2394-6040.ijcmph20232351
Gebreweld A, Fiseha T, Kebede E, Tamir Z, Gebremariam B, Miruts F, et al. Immuno-hematological and biochemical changes in patients with tuberculosis in dessie comprehensive specialized hospital, dessie, Ethiopia. J Blood Med. 2024;15:147-55. DOI: https://doi.org/10.2147/JBM.S445857
Kumar SR, Kandhasamy C, Velayutham VB, Chinnaiyan P, Kannan M, Jawahar MS, et al. Hematological Parameters in Patients with Pulmonary Tuberculosis and its Presentation among Favorable and Unfavorable Treatment Outcomes. Indian J Public Health. 2024;68(3):362-5. DOI: https://doi.org/10.4103/ijph.ijph_918_23
Abay F, Yalew A, Shibabaw A, Enawgaw B. Hematological abnormalities of pulmonary tuberculosis patients with and without HIV at the University of Gondar Hospital, Northwest Ethiopia: a comparative cross-sectional study. Tuberc Res Treat. 2018;2018:1-6.
Daniel Adewole P, Deborah Ogundipe T, Samuel Alabi O, Nuhu A. Haematological parameter among drug resistant tuberculosis patients in Ibadan. Afr Health Sci. 2024;24(1):10-5. DOI: https://doi.org/10.4314/ahs.v24i1.3
Jesson LK, Barrett SCH. The Comparative Biology of Mirror‐Image Flowers. Int J Plant Sci. 2003;164(S5):S237-S249. doi:10.1086/378537 DOI: https://doi.org/10.1086/378537
Lai JL, Chen YH, Liu YM, Yuan JJ, Lin J, Huang AQ, et al. Prevalence and risk factors of anaemia in hospitalised HIV-infected patients in southeast China: a retrospective study. Epidemiol Infect. 2019;147:e81. DOI: https://doi.org/10.1017/S0950268818003618
Isibor CN, Adu ME. Haematological evaluation of mycobacterium tuberculosis subjects at Central Hospital Agbor, Nigeria. Sokoto J Med Lab Sci. 2022;7(1):44-51. DOI: https://doi.org/10.4314/sokjmls.v7i1.5
Lee SW, Kang YA, Yoon YS, Um SW, Lee SM, Yoo CG, et al. The prevalence and evolution of anemia associated with tuberculosis. J Korean Med Sci. 2006;21(6):1028. DOI: https://doi.org/10.3346/jkms.2006.21.6.1028
Alamlih L, Albakri M, Ibrahim WH, Khan A, Khan FY. Hematologic characteristics of patients with active pulmonary, extra-pulmonary and disseminated tuberculosis: a study of over six hundred patients. J Tuberc Res. 2020;08(02):33-41. DOI: https://doi.org/10.4236/jtr.2020.82004
Ullah K, Ullah A, Ullah I, Khan K, Ullah W. Assessment of hematological parameters in mycobacterium tuberculosis-infected patients at Hayatabad Medical Complex, Peshawar, Pakistan: hematological profile in TB patients. Journal of Health and Rehabilitation Research. 2024;4(3):1-5. DOI: https://doi.org/10.61919/jhrr.v4i3.1585
Vamja R, Parmar PA, Makwana N, Sundar R. Haematological markers as predictive tools for tuberculosis in PLHIV: a retrospective cohort study in Gujarat, India. BMC Infect Dis. 2025;25(1):228. DOI: https://doi.org/10.1186/s12879-025-10625-y
Pratap Singh U, Tilkar M, Singh U, Maravi A, Baghel PK, Professor A. To study haematological profile in patient of pulmonary tb with and without HIV co-infection. Eur J Mol Clin Med. 2021;8:1709-18.
Abay F, Yalew A, Shibabaw A, Enawgaw B. Hematological abnormalities of pulmonary tuberculosis patients with and without HIV at the University of Gondar Hospital, northwest Ethiopia: a comparative cross-sectional study. Tuberc Res Treat. 2018;2018:1-6. DOI: https://doi.org/10.1155/2018/5740951
Anil W, Sourya A, Anirudh PS, Chetan Rathi. A study of hematological profile in HIV/AIDS. Int J Health Sci Res. Aids. 2013;8(9).
Iqbal S, Ahmed U, Khan MA. Hematological parameters altered in tuberculosis. Pak J Physiol. 2015;11(1):13-6.
Shah AR, Desai KN, Maru AM. Evaluation of hematological parameters in pulmonary tuberculosis patients. J Fam Med Prim Care. 2022;11(8):4424-8. DOI: https://doi.org/10.4103/jfmpc.jfmpc_2451_21
Li F, Chen D, Zeng Q, Du Y. Possible mechanisms of lymphopenia in severe tuberculosis. Microorganisms. 2023;11(11):2640. DOI: https://doi.org/10.3390/microorganisms11112640
Shafee M. Hematological profile and risk factors associated with pulmonary tuberculosis patients in Quetta, Pakistan. Pak J Med Sci. 1969;30(1). DOI: https://doi.org/10.12669/pjms.301.4129